Brain-derived neurotrophic factor activation of TrkB protects neurons from HIV-1/gp120-induced cell death

Critical Reviews in Neurobiology

Volumn 16, Issue 1-2, 2004, Pages 51-57

  Mocchetti, Italo ^a   Bachis, Alessia ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

AIDS; BDNF; Caspase 3; Cerebellar granule cells; ERK; Gp120; K252a; Neuroprotection; U0126

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; CASPASE 3; GLYCOPROTEIN GP 120; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; APOPTOSIS; BRAIN ATROPHY; ENZYME ACTIVATION; GRANULE CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; NEUROPROTECTION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CASPASE 3; CASPASES; CELL DEATH; GENE EXPRESSION REGULATION; HIV ENVELOPE PROTEIN GP120; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASES; NEURONS; RECEPTOR, TRKB;

EID: 9744260297     PISSN: 08920915     EISSN: None     Source Type: Journal    
DOI: 10.1615/CritRevNeurobiol.v16.i12.50     Document Type: Review

References (38)

1. McArthur JC, Haughey N, Gartner S, Conant K, Pardo C, Nath A, et al. Human immunodeficiency virus-associated dementia: an evolving disease. J Neurovirol 2003; 2:205-221.
2. Brew BJ, Rosenblum M, Cronin K, Price RW. AIDS dementia complex and HIV-1 brain infection: clinical-virological correlations. Ann Neurol 1995; 38: 563-570.
3. Jones MV, Bell JE, Nath A. Immunolocalization of HIV envelope gp120 in HIV encephalitis with dementia. AIDS 2000; 14:2709-2713.
4. Wiley CA, Masliah E, Morey M, Lemere C, De-Teresa R, Grafe M, et al. Neocortical damage during HIV infection. Ann Neurol 1991; 29:651-657.
5. Everall IP, Luthert PJ, Lantos PL. Neuronal loss in the frontal cortex in HIV infection. Lancet 1991; 337:1119-1121.
6. Masliah E, Heaton RK, Marcotte TD, Ellis RJ, Wiley CA, Mallory M, et al. Dendritic injury is a pathological substrate for human immunodeficiency virus-related cognitive disorders. HNRC Group. The HIV Neurobehavioral Research Center. Ann Neurol 1997; 42:963-672.
7. Dal Pan GJ, McArthur JH, Aylward E, Seines OA, Nance-Sproson TE, Kumar AJ, et al. Patterns of cerebral atrophy in HIV-1-infected individuals: results of a quantitative MRI analysis. Neurology 1992; 42: 2125-2130.
8. Lopez-Villegas D, Lenkinski RE, Frank I. Biochemical changes in the frontal lobe of HIV-infected individuals detected by magnetic resonance spectroscopy. Proc Natl Acad Sci USA 1997; 94: 9854-9859.
9. Stout JC, Ellis RJ, Jernigan TL, Archibald SL, Abramson I, Wolfson T, et al. Progressive cerebral volume loss in human immunodeficiency virus infection: a longitudinal volumetric magnetic resonance imaging study. HIV Neurobehavioral Research Center Group. Arch Neurol 1998; 55:161-168.
10. Kolson DL. Neuropathogenesis of central nervous system HIV-1 infection. Clin Lab Med 2002; 22: 703-717.
11. Bagetta G, Corasaniti MT, Aloe L, Berliocchi L, Costa N, Finazzi-Agro A, et al. Intracerebral injection of human immunodeficiency virus type 1 coat protein gp120 differentially affects the expression of nerve growth factor and nitric oxide synthase in the hippocampus of rat. Proc Natl Acad Sci USA 1996; 93:928-933.
12. Maccarrone M, Bari M, Corasaniti MT, Nistico R, Bagetta G, Finazzi-Agro' A. HIV-1 coat glycoprotein gp120 induces apoptosis in rat brain neocortex by deranging the arachidonate cascade in favor of prostanoids. J Neurochem 2000; 75:196-203.
13. Bansal AK, Mactutus CF, Nath A, Maragos W, Hauser KF, Booze RM. Neurotoxicity of HIV-1 proteins gp120 and Tat in the rat striatum. Brain Res 2002; 879:42-49.
14. lV-derived gp120 alter spatial memory, LTP, and sleep in rats. Neurobiol Dis 2000; 7: 384-394.
15. Acquas E, Bachis A, Nosheny R, Cernak I, Mocchetti I. Human immunodeficiency virus type 1 envelope protein gp120 causes neuronal cell death in the rat brain by activating caspases. Neurotox Res 2004; 5:605-616.
16. Toggas SM, Masliah E, Rockenstein EM, Rall GF, Abraham CR, Mucke L. Central nervous system damage produced by expression of the HIV-1 coat protein gp120 in transgenic mice. Nature 1994; 367: 188-193.
17. Yuan J, Lipinski M, Degterev A. Diversity in the mechanisms of neuronal cell death. Neuron 2003; 40:401-413.
18. Bonfoco E, Krainic D, Ankarcrona M, Nicotera P, Lipton SA. Apoptosis and necrosis: two distinct events induced respectively by mild and intense insult with N-methyl-D-aspartate or nitric oxide/Superoxide in cortical cell culture. Proc Natl Acad Sci USA 1995; 92:7162-7166.
19. Yuan J, Yankner BA. Apoptosis in the nervous system. Nature 2000; 407:802-809.
20. Kaul M, Lipton SA. Chemokines and activated macrophages in HIV gp120-induced neuronal apoptosis. Proc Natl Acad Sci USA 1999; 96:8212-8216.
21. Hesselgesser J, Taub D, Baskar P, Greenberg M, Hoxie J, Kolson DL, et al. Neuronal apoptosis induced by HIV-1 gp120 and the chemokine SDF-1 alpha is mediated by the chemokine receptor CXCR4. Curr Biol 1998; 8:595-598.
22. Bachis A, Major EO, Mocchetti I. Brain-derived neurotrophic factor inhibits HIV-l/gpl20-mediated cerebellar granule cell death by preventing gp120 internalization. J Neurosci 2003; 23:5715-5722.
23. James HJ, Sharer LR, Zhang Q, Wang HG, Epstein LG, Reed JC, et al. Expression of caspase-3 in brains from pediatric patients with HIV-1 encephalitis. Neuropathol Appl Neurobiol 1999; 25:380-386.
24. Reichardt LF. Neurotrophic factors: a window into the nervous system. In: Mocchetti I, editor. Neurobiology of the Neurotrophins. Johnson City, TN: RP. Graham, 2001.
25. Altar AC, Boylan CB, Jackson C, Hershenson S, Miller J, Wiegand SJ, et al. Brain-derived neurotrophic factor augments rotational behavior and nigrostriatal dopamine turnover in vivo. Proc Natl Acad Sci USA 1992; 89:11347-11351.
26. Hyman C, Hofer M, Barde Y-A. BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature 1991; 350:369-377.
27. Lindholm D, Dechant G, Heisenberg CP, Thoenen H. Brain derived neurotrophic factor is a survival factor for cultured rat cerebellar granule neurons and protects against glutamate-induced neurotoxicity. Eur J Neurosci 1993; 5:1455-1464.
28. Marini AM, Rabin SJ, Lipski R, Mocchetti I. Activity-dependent release of BDNF underlies the neuroprotective effect of NMDA. J Biol Chem 1998; 273:29394-29399.
29. Bhave SV, Ghoda L, Hoffman PL. Brain-derived neurotrophic factor mediates the anti-apoptotic effect of NMDA in cerebellar granule neurons: signal transduction cascades and site of ethanol action. J Neurosci 1999; 19:3277-3286.
30. Bothwell M. Neurotrophin receptors. In: Mocchetti I, editor. Neurobiology of the Neurotrophins. Johnson City, TN: F.P. Graham, 2001.
31. Chao MV. Neurotrophins and their receptors: a convergence point for many signaling pathways. Nature Rev Neurosci 2003; 4:299-309.
32. Kaplan DR, Miller FD. Neurotrophin signal transduction in the nervous system. Curr Opin Neurobiol 2000; 10:381-391.
33. Bonni A, Brunet A, West AE, Datta SR, Takasu MA, Greenberg ME. Cell survival prompted by Ras-MAPK signaling pathway by transcription-dependent and independent mechanisms. Science 1999; 286:1358-1362.
34. Xia Z, Dickens M, Raingenaud J, Davis RJ, Greenberg ME. Opposing effects of ERK and JUN-p38 MAP kinases on apoptosis. Science 1995; 270: 1326-1331.
35. Han BH, Holtzman DM. BDNF protects the neonatal brain from hypoxic-ischemic injury in vivo via the ERK pathway. J Neurosci 2000; 20:5775-5781.
36. Kawashaki H, Morooka T, Shoiimohama S, Kimura J, Hirano T, Gotoh y, et al. Activation and involvement of p38 mitogen-activated protein kinase in glutamate-induces apoptosis in rat cerebellar granule cells. J Biol Chem 1997; 272:18518-18521.
37. Bachis A, Mocchetti I. The chemokine receptor CXCR4 and not N-methyl-D-aspartate receptor mediates gp120 neurotoxicity in cerebellar granule cells. J Neurosci Res 2004; 75:75-82.
38. Johnson MD, Kinoshita Y, Xiang H, Ghatan S, Morrison RS. Contribution of p53-dependent caspase activation to neuronal cell death declines with neuronal maturation. J Neurosci 1999; 19:2996-3004.